Table 2 Demographics for the uptake experiments

From: Implication of the glutamate–cystine antiporter xCT in schizophrenia cases linked to impaired GSH synthesis

 

Patients

Controls

GCLC

Low-risk

High-risk

Low-risk

n =

11

8

9

Age in years (s.d)

22.6 (3.5)

22.3 (3.2)

23.5 (3.6)

Sex (males/females)

11 / 0

8 / 0

9 / 0

Diagnostic

   

Schizophrenia

9

6

–

Schizo-affective

1

1

–

Schizophreniform

1

1

–

Illness duration in years (sd)

3.8 (3.2)

2.0 (1.2)

–

Medication in CPZ

303 (247)

301 (265)

–

  1. s.d. standard deviation, CPZ chlorpromazine equivalents
Back to article page